title: [Urogenital chlamydia infection: treatment with wilprafen].
abstract: Antibiotic wilprafen (josamycin) was given in a dose 500 mg per os two times a day for 15 days to 30 male patients with a long history of chronic Chlamydia trachomatis infection (CTI) treated ineffectively. The control examination has not detected Chlamydia in 29 (96.5%) patients. The results demonstrate high efficacy of the drug wilprafen in the treatment of patients with urogenital CTI.
authors.forename: A I
authors.initials: AI
authors.lastname: Iakubovich
authors.forename: A E
authors.initials: AE
authors.lastname: Chuprin
authors.forename: D A
authors.initials: DA
authors.lastname: Rakitin
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002690:Chlamydia Infections / Q000188:drug therapy*; D002692:Chlamydia trachomatis; D005500:Follow-Up Studies; D006801:Humans; D015570:Josamycin / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D052801:Male Urogenital Diseases / Q000188:drug therapy*; D008875:Middle Aged; D012737:Sex Factors; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents; D015570:Josamycin